Login

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
ASSETS
Current assets:
Cash and cash equivalents
Investments
Trade accounts receivable, net
Inventory
Prepaid expenses
Purchase obligation - put option asset
Other current assets
Total current assets
Property and equipment, net
Finance lease assets, net
Operating lease right-of-use assets, net
Other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable
Accrued liabilities
Accrued interest
Deferred revenue and income, current
Current portion of long-term debt
Current portion of convertible notes
Notes payable, current
Warrant liability
Finance lease, current
Operating lease, current
Derivative liability
Total current liabilities
Finance lease, non-current
Operating lease, non-current
Deferred revenue and income, non-current
Other non-current liabilities
Accrued interest related-party
Long-term debt related-party
Convertible notes
Accrued interest, related-party
Related Party
Total accrued interest, related-party
Long-term debt related-party
Related Party
Total long-term debt related-party
Long-term debt, related-party
Notes payable, non-current
Convertible notes, non-current
Total liabilities
Stockholders' deficit:
Preferred shares, $0.001 par value; 5,000,000 preferred shares authorized with no shares issued and outstanding at December 31, 2024 and no shares issued and outstanding at December 31, 2023
Common stock, $0.001 par value 200,000,000 common shares authorized with 97,477,546 shares issued and outstanding on December 31, 2022 and 100,000,000 common shares authorized with 67,649,018 shares issued and outstanding on December 31, 2021
Common stock, $0.001 par value; 450,000,000 common shares authorized with 14,357,953 shares issued and outstanding on June 30, 2023 and 200,000,000 common shares authorized with 9,747,755 shares issued and outstanding on December 31, 2022
Common stock, $0.001 par value; 450,000,000 common shares authorized with 25,186,582 shares issued and outstanding at December 31, 2024 and 450,000,000 common shares authorized with 14,569,500 shares issued and outstanding at December 31, 2023
Contributed capital
Treasury stock
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' deficit
Total liabilities and stockholders' deficit
Preferred Stock, par value (usd per share)
Preferred Stock, shares authorized (shares)
Convertible Notes Payable, Current

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support